End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1134 USD | +6.98% | -1.73% | -42.73% |
11/04 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
13/02 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
Chart calendar Onconetix, Inc.
Upcoming events on Onconetix, Inc.
No events available
Past events on Onconetix, Inc.
31/05/2023 | Annual General Meeting |
16/05/2023 01:00 am | JMP Securities Life Sciences Conference |
13/05/2023 04:02 am | Q1 2023 Earnings Release |
20/04/2023 06:00 pm | Business Update Call |
09/03/2023 07:01 pm | Q4 2022 Earnings Release |
12/01/2023 04:00 am | JP Morgan Healthcare Conference |
07/12/2022 10:30 pm | Investor Meeting - Key Opinion Leader |
02/12/2022 12:25 am | World Vaccine & Immunotherapy Congress |
10/11/2022 07:18 pm | Q3 2022 Earnings Release |
26/10/2022 | LD Micro Main Event XV |
13/10/2022 06:15 pm | World Vaccine Congress |
13/10/2022 02:30 pm | World Vaccine Congress |
12/10/2022 02:30 pm | World Vaccine Congress |
12/09/2022 06:30 pm | H.C. Wainwright Global Investment Conference |
05/09/2022 | Universal Influenza Vaccines Conference |
16/08/2022 01:30 am | Interim 2022 Earnings Release |
15/06/2022 09:00 pm | JMP Securities Life Sciences Conference |
25/05/2022 06:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
14/05/2022 02:31 am | Q1 2022 Earnings Release |
21/04/2022 03:25 am | World Vaccine Congress |
Annual results
Fiscal Period | December | 2021 | 2022 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | 0,00 | -11,5 -11,6 0.86% |
EBIT Million USD | Released Forecast Spread | 0,00 | -13,5 -14,3 5.72% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -13,4 -14,3 6.04% |
Net income Million USD | Released Forecast Spread | -3,42 | -13,4 -14,3 6.37% |
EPS USD | Released Forecast Spread | -1,26 | -1,10 -1,19 7.56% |
Announcement Date | 31/03/22 | 09/03/23 |
Quarterly results
Fiscal Period | December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -3,25 -4,08 20.47% | -2,85 -3,35 15.02% | -6,65 -3,13 -112.24% | -4,49 -3,45 -30.24% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,22 -4,08 21.16% | -2,85 -3,35 15.06% | -6,87 -3,13 -119.13% | -5,35 -3,45 -55.16% |
Net income Million USD | Released Forecast Spread | -3,22 -4,08 21.16% | -2,85 -3,35 15.06% | -6,87 -3,13 -119.13% | -5,35 -3,45 -55.16% |
EPS USD | Released Forecast Spread | -0,16 -0,27 39.62% | -0,18 -0,21 12.2% | -0,43 -0,18 -138.89% | -0,31 -0,19 -63.16% |
Announcement Date | 09/03/23 | 12/05/23 | 20/10/23 | 17/11/23 |
11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Onconetix, Inc.
14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
13/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
09/05/2024 01:35 am | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONCO Stock
- Calendar Onconetix, Inc.